Paul Hastings LLP advised BofA Securities, Inc. and Goldman Sachs & Co. LLC as joint lead placement agents in connection with Arvinas, Inc.’s (Nasdaq: ARVN) private placement. The total gross proceeds from the offering are expected to be approximately $350 million. Arvinas is a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation.

Partner and co-head of Equity Capital Markets and co-chair of the Corporate Life Sciences Group Seo Salimi and Capital Markets partner Will Magioncalda led the Paul Hastings team, which also included associate Chris Guerin.

More details about the transaction can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.